ACCARDI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 447
EU - Europa 395
AS - Asia 204
AF - Africa 14
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.070
Nazione #
US - Stati Uniti d'America 431
SE - Svezia 134
CN - Cina 109
IE - Irlanda 80
SG - Singapore 63
IT - Italia 54
DE - Germania 28
TR - Turchia 27
FR - Francia 21
CA - Canada 16
CI - Costa d'Avorio 14
RO - Romania 13
BE - Belgio 10
FI - Finlandia 10
AT - Austria 9
GB - Regno Unito 9
CZ - Repubblica Ceca 8
BR - Brasile 7
ES - Italia 4
UA - Ucraina 3
BG - Bulgaria 2
EU - Europa 2
IN - India 2
LT - Lituania 2
NL - Olanda 2
RU - Federazione Russa 2
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
IR - Iran 1
LU - Lussemburgo 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
Totale 1.070
Città #
Chandler 110
Dublin 80
Singapore 48
Ashburn 39
Ann Arbor 34
Izmir 24
Shanghai 23
Boardman 21
Dearborn 21
New York 20
Parma 16
Nanjing 15
Toronto 15
Abidjan 14
Santa Clara 14
Focsani 13
Marseille 13
Munich 13
Princeton 13
Beijing 11
Brussels 10
Helsinki 10
Vienna 9
Hebei 8
Bremen 7
Shenyang 7
Brno 6
Los Angeles 6
Romainville 6
Milan 5
Rho 5
Wilmington 5
Hefei 4
Kunming 4
Madrid 4
Nanchang 4
San Mateo 4
Changsha 3
Des Moines 3
Guangzhou 3
Jinan 3
Kocaeli 3
Norwalk 3
Rome 3
Tianjin 3
Woodbridge 3
Zhengzhou 3
Dallas 2
Deiva Marina 2
Florence 2
Jacksonville 2
Jiaxing 2
London 2
Modena 2
Redwood City 2
Seattle 2
Torino 2
Waltham 2
Afogados da Ingazeira 1
Amsterdam 1
Aosta 1
Belgrade 1
Belo Horizonte 1
Borås 1
Bragança Paulista 1
Buffalo 1
Candelária 1
Chengdu 1
Cúcuta 1
Dhaka 1
Edinburgh 1
Frankfurt am Main 1
Fremont 1
Haikou 1
Harbin 1
Houston 1
Huizen 1
Itaquaquecetuba 1
Luxembourg 1
Matera 1
Miami 1
Moscow 1
Mountain View 1
Orange 1
Oslo 1
Ottawa 1
Ourilândia do Norte Municipality 1
Paris 1
Radomir 1
Sabz 1
Salvador 1
San Francisco 1
Sofia 1
Somerville 1
Velletri 1
Vitebsk 1
Volgograd 1
Walnut 1
Xian 1
Totale 754
Nome #
The Proteasome and Myeloma-Associated Bone Disease 103
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 103
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 103
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 90
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 89
Novel targets for the treatment of relapsing multiple myeloma 89
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 78
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 77
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 73
Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma 72
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 71
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 68
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 61
CD38 expression by plasma cells in extramedullary multiple myeloma 25
Totale 1.102
Categoria #
all - tutte 4.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 0 0 0 0 0 25 12 2 14 12 1 4
2020/202162 2 1 6 1 21 4 2 2 11 4 3 5
2021/2022107 1 4 3 22 0 2 17 5 4 3 16 30
2022/2023395 58 54 19 29 46 29 23 16 96 4 16 5
2023/2024147 3 11 3 4 16 46 7 9 1 7 10 30
2024/2025179 17 18 28 59 56 1 0 0 0 0 0 0
Totale 1.102